Global Poultry Vaccine Market was worth of USD 2.06 Billion in 2020 and it is expected to reach USD 3.07 Billion by the end of 2027 with the CAGR of 6.2% during Forecast Period.
Global Poultry Vaccine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis To 2021-2027,Rising number of veterinary practitioners and technological advancements has anticipated the growth of the global poultry vaccine market. Along with these factors, the rising adoption of live poultry and increasing of avian disease has boosted the growth of global Poultry Vaccine market.
Poultry disease mainly occurs in Poultry species such as chicken, duck, ostrich, and goose. Symptoms of poultry disease are facial edema, cyanosis of comb, sudden death, paralysis of wings and legs, and decline in egg production. Poultry vaccine is used widely to prevent and control contagious poultry diseases. Poultry are usually vaccinated against the variety of disease including the marek’s, Newcastle disease, infectious bronchitis, Infectious Laryngotracheitis, and fowl pox. Poultry supplier and hatcheries are the best source of vaccines. Poultry vaccine produce large dose vials which are used as commercial. This vaccination is the convenient way to vaccine manufacturers and commercial producers who are often have thousands of birds which need to vaccinate at a time. The isolation of marek’s disease (MD) herpes virus was developed in England in the year 1960s. It was the first cell-culture-isolated MDV strain, by passaging HPRS-16 in chick kidney cells. HPRS-16/Att was replaced by the FC126 strain of herpes virus of turkeys which was developed by the witter and his associates.
COVID-19 pandemic has affected economic and social life in many ways. This has also shown a negative impact on the production of poultry market which in turn has adverse effect in production of poultry vaccine. Governments has action taken for preventing the spread of coronavirus, which in turn resulted on the travel restrictions, border closures, including national lockdown have badly affected the poultry vaccine market. According to the frontiersin.org, 8.5 million people are working in the poultry sectors which hampered the production, marketing of chicken and eggs. According to the USDA, in the year 2020 egg exports was at 311 million dozens, which is decrease by 7% as compared to the export in the year 2019.
Global poultry vaccine market is segmented on the basis of product type, disease, dosage form, and region and country level. Based on the product type the global poultry vaccine market is classified into attenuated vaccine, inactivated vaccine, DNA vaccine, recombinants vaccine and others. Based on the disease the global poultry vaccine market is classified into marek’s disease, newcastle disease, infectious bronchitis, avian influenza and others. Based on the dosage form the global poultry vaccine market is classified into freeze dried vaccine, liquid vaccine, duct, and others.
Some major key players for global Poultry Vaccine market report cover prominent players like
May 26th, 2021: A single shot for the poultry vaccine in India has been launched by the Boehringer Ingelheim as “VAXXITEK HVT+IBD”. This vaccine gives protection to the chicken, such as broiler, breeder, and layer. The vaccine protect against two major diseases such as Marek's Disease and infectious Bursal Disease. Vaccine has covered almost 130 billion birds that are vaccinated globally and is available in 100 countries. As an innovative single-dose recombinant vaccine and it eliminates the need of additional vaccine. VAXXITEK HVT+IBD has provide a very effective and simplified solution to the Indian poultry market and expected to protect against two avian disease in one product.
Veterinary practitioners are increasing day by day and technological advancements have anticipated the growth of the global poultry vaccine market. Along with these factors, the rising adoption of live poultry and increasing of avian disease has boosted the growth of global poultry market.
The major factor that drives the market is veterinary practitioners and vaccination are increasing day by day and technological advancements. Veterinary vaccines have major impact on not only in production and animal health but also in human health while consuming poultry products and to have safe food supplies. Vaccination is carried out in various poultries and farms to prevent the spread of different disease. Many types of vaccines that are given in poultry are BCRDV vaccines, RDV vaccines, gumboro live vaccines, marek’s vaccines and many more. According to the newindianexpress, almost 400 birds have died at poultry farm at Nizamabad district (India).
The other factor that is fueling this global poultry vaccine market is increasing awareness of avian disease and adoption of live poultry. The highest outbreak of avian disease in wild bird and poultry in some European countries, killing millions of birds which was due to the pathogenic virus subtype A (H5N8). This can also infect the humans when come in contact with the infected bird or poultry products resulting in the upper respiratory symptoms which can further leads to acute respiratory distress syndrome. According to the WHO, almost 239 cases of human infection occurred with avian disease. The restraining factor that can hamper the growth of the market is the lack of information about diseases, high cost of veterinary service in undeveloped countries. The rapid growth of the poultry population will give tremendous opportunity over the forecast period. According to the national chicken council, in 2018, more than 9 billion broiler chickens, weighing 56.5 billion pounds were produced world-wide.
North America has a significant share in poultry vaccine owing to the consumption of poultry products and rising awareness in the safety of poultry food due to the high lifestyle in people. According to the USDA, U.S. is consuming almost 65.2 pounds of chicken per person in the year 2018. According to the national chicken council, United States has the largest broiler chicken industry in the world consisting around 17% of the production and consuming almost 42.5 million pounds of chicken products. High lifestyle will also lead to the awareness of the food safety in the poultry food among people have boosted the market growth. Poultry is the primary source of animal protein. U.S is the largest poultry meat producers in the world. According to the fao, U.S. in the second largest producer of egg with 7% and around 58 billion chickens are present in North America in 2019.
Asia pacific is expected to expand the growth of the poultry vaccine market due to the government initiatives program for poultry vaccination and increasing poultry production. Different programs run by the government for poultry vaccination is fueling the market. In most of the Asian countries there are routine vaccination programs such as infectious avian encephalomyelitis, Newcastle disease, Marek's disease etc. Developed poultry industries are following the onsite biosecurity programs for preventing most infectious diseases which is supported by the close veterinary. The vaccination plan on H9N2 has minimized the egg defects, increased production and prevented the egg shell quality. According to the veterinary research, almost 93.89 % of the chicken has infected by the H9N2 virus.
Other factor that drives the market is the production of poultry production in the Asia pacific region. Asia is the largest egg production region, accounting for 64% of the global output. According to the fao.org, China is the largest egg producer with 37% followed by Indian with 6 % world-wide. Additionally, according to the fao, the total number of chicken in Asia during 2019 was 15.8 billion. For instance, according to the pubmed, the bivalent inactivated vaccine for chickens was introduced in China, and the H7N9 virus isolation rate in poultry dropped by 93.3% after vaccination in the year 2017.
The regions covered in this global poultry vaccines market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East ,GCC, (UAE, Saudi Arabia, Kuwait) Africa, etc.
Middle East and Africa
|Historical data||2015 - 2020|
|Forecast Period||2022 - 2028|
|Market Size in 2020:||
USD 2.06 Billion
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2027:||
USD 3.07 Billion
|Tables, Charts & Figures:||175|
Elanco, Biovac, Ceva, Phibro Animal Health Corporation, Zoetis Inc, Hester Biosciences Limited, Merck & Co. Inc., AniCon Labor GmbH (SAN Group), Boehringer Ingelheim International GmbH, Venkys India, Calier, KM Biologics, Vaxxinova International BV, Ringpu Biology, and others.
By Product Type, By Disease, By Dosage Form.
|Regional Analysis||North America, U.S., Canada, , Europe, Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe, Asia-Pacific, South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC, Latin America, Mexico, Colombia, Brazil, Argentina, Peru, Rest of South America, Middle East and Africa, Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA|